Pharma Business - October 8, 2025
Xspray Pharma’s FDA approval delayed
FDA has issued a Complete Response Letter regarding Xspray’s New Drug Application for Dasynoc, referring to GMP observations at a contract manufacturer.
Business article - October 6, 2025
Novo Nordisk ends collaboration with Heartseed
As part of Novo Nordisk's restructuring, the company has chosen to discontinue its cell therapy collaboration with Heartseed.
Financing - September 30, 2025
Orexo US awarded USD 8 million by BARDA
The company's wholly owned US subsidiary, Orexo US has been awarded funding by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the US Department of Health and Human Services.
Global report - September 29, 2025
AstraZeneca switch to direct US listing, keeps UK listing
AstraZeneca plans to harmonize its share listing structure to deliver "a global listing for global investors in a global company".
CDMO - September 24, 2025
PolyPeptide Group achieves milestone in Malmö expansion
PolyPeptide Group has announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility.
Acquisition - September 22, 2025
Kancera to seek stakeholders for a reverse take over
The company's board has decided to initiate a process to seek potential stakeholders for a reverse take over of the company with the aim to materialize the value of its public listing.
